High-efficacy DMTs More Effective at Slowing Retina Atrophy in RRMS Patients episode artwork

EPISODE · Oct 12, 2020 · 13 MIN

High-efficacy DMTs More Effective at Slowing Retina Atrophy in RRMS Patients

from MS News & Perspectives · host MS News Today

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how high-efficacy DMT’s are more effective in slowing retinal atrophy in those patients with RRMS.Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her DISabled to ENabled column entitled How to Cope and Thrive During a Challenging Time.=====================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.http://ChangesInRMS.com=====================================Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ =====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/

Episode metadata supplied by the publisher feed · Published Oct 12, 2020

Embed this episode

NOW PLAYING

High-efficacy DMTs More Effective at Slowing Retina Atrophy in RRMS Patients

0:00 13:05

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MS News & Perspectives?

This episode is 13 minutes long.

When was this MS News & Perspectives episode published?

This episode was published on October 12, 2020.

Can I download this MS News & Perspectives episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!